{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:10:55Z","timestamp":1789161055140,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jaut.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T07:56:10Z","timestamp":1221638170000},"page":"339-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity"],"prefix":"10.1016","volume":"31","author":[{"given":"Nagako","family":"Akeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Blackard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2008.08.001_bib1","first-page":"107","article-title":"Infection, thyroid disease and autoimmunity","volume":"14","author":"Tomer","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaut.2008.08.001_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0950-351X(95)80819-1","article-title":"Infections and autoimmune endocrine disease","volume":"9","author":"Tomer","year":"1995","journal-title":"Bailli\u00e8re's Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaut.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2004.04.004","article-title":"Hepatitis C and thyroid autoimmunity: is there a link?","volume":"117","author":"Tomer","year":"2004","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jaut.2008.08.001_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","article-title":"Interferon alpha treatment and thyroid dysfunction","volume":"36","author":"Tomer","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.jaut.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hep.1840180205","article-title":"High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy","volume":"18","author":"Tran","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/jaut.1999.0360","article-title":"Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study","volume":"14","author":"Ganne-Carrie","year":"2000","journal-title":"J Autoimmun"},{"issue":"13","key":"10.1016\/j.jaut.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","article-title":"Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy","volume":"158","author":"Fernandez-Soto","year":"1998","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jaut.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","article-title":"Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a","volume":"132","author":"Preziati","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jaut.2008.08.001_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jaut.2000.0488","article-title":"Hepatitis C and D, retroviruses and autoimmune manifestations","volume":"16","author":"Obermayer-Straub","year":"2001","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.jaut.2008.08.001_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2006.07.005","article-title":"Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity","volume":"27","author":"Toubi","year":"2006","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.jaut.2008.08.001_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.21283","article-title":"Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences","volume":"44","author":"Blackard","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.510280531","article-title":"Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues","volume":"28","author":"Laskus","year":"1998","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jaut.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/378643","article-title":"Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism","volume":"188","author":"Munshi","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jaut.2008.08.001_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/505708","article-title":"Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes","volume":"194","author":"Balasubramanian","year":"2006","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2008.08.001_bib18","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/429493","article-title":"Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV","volume":"41","author":"Balasubramanian","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"37","key":"10.1016\/j.jaut.2008.08.001_bib19","doi-asserted-by":"crossref","first-page":"35755","DOI":"10.1074\/jbc.M302889200","article-title":"Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes","volume":"278","author":"Balasubramanian","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaut.2008.08.001_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.gene.6364375","article-title":"A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression","volume":"8","author":"Jacobson","year":"2007","journal-title":"Genes Immun"},{"issue":"33","key":"10.1016\/j.jaut.2008.08.001_bib21","doi-asserted-by":"crossref","first-page":"23414","DOI":"10.1074\/jbc.274.33.23414","article-title":"Involvement of protein kinase C epsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis","volume":"274","author":"Knauf","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.jaut.2008.08.001_bib22","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/JVI.73.8.6235-6244.1999","article-title":"Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81","volume":"73","author":"Flint","year":"1999","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.jaut.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.3748\/wjg.v10.i20.2972","article-title":"Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells","volume":"10","author":"Zhu","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jaut.2008.08.001_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"6690","key":"10.1016\/j.jaut.2008.08.001_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/28282","article-title":"Autoimmunity. The pathogen connection","volume":"394","author":"Benoist","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jaut.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/jaut.2000.0482","article-title":"Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals","volume":"16","author":"Fournie","year":"2001","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.jaut.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0798-781","article-title":"Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry","volume":"4","author":"Horwitz","year":"1998","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2006.03.011","article-title":"By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse","volume":"121","author":"Arata","year":"2006","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaut.2008.08.001_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hep.21321","article-title":"Hepatitis C virus entry: molecular biology and clinical implications","volume":"44","author":"Barth","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2008.08.001_bib30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/hep.21191","article-title":"Host cell responses induced by hepatitis C virus binding","volume":"43","author":"Fang","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20011124","article-title":"Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein","volume":"195","author":"Crotta","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jaut.2008.08.001_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells","volume":"31","author":"Wack","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2008.08.001_bib33","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jaut.2008.08.001_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.autrev.2007.03.010","article-title":"The pathophysiology of HCV induced B-cell clonal disorders","volume":"6","author":"Landau","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2008.08.001_bib35","doi-asserted-by":"crossref","first-page":"15119","DOI":"10.1073\/pnas.2434175100","article-title":"Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease","volume":"100","author":"Ban","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.jaut.2008.08.001_bib36","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A Graves\u2019 disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.jaut.2008.08.001_bib37","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","article-title":"CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease","volume":"165","author":"Kouki","year":"2000","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jaut.2008.08.001_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/hmg\/8.7.1195","article-title":"The cytotoxic T lymphocyte antigen-4 is a major Graves\u2019 disease locus","volume":"8","author":"Vaidya","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaut.2008.08.001_bib39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.gene.6364018","article-title":"Analysis of the CTLA-4, CD28 and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease","volume":"4","author":"Ban","year":"2003","journal-title":"Genes Immun"},{"issue":"6939","key":"10.1016\/j.jaut.2008.08.001_bib40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jaut.2008.08.001_bib41","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1210\/jc.2004-1108","article-title":"The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves\u2019 disease","volume":"89","author":"Velaga","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jaut.2008.08.001_bib42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.ejhg.5201485","article-title":"Association of the TSHR gene with Graves\u2019 disease: the first disease specific locus","volume":"13","author":"Dechairo","year":"2005","journal-title":"Eur J Hum Genet"},{"issue":"1-2","key":"10.1016\/j.jaut.2008.08.001_bib43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","article-title":"The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology","volume":"30","author":"Jacobson","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2008.08.001_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","article-title":"Arginine at position 74 of the HLA-DRb1 chain is associated with Graves\u2019 disease","volume":"5","author":"Ban","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaut.2008.08.001_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","article-title":"The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future","volume":"28","author":"Jacobson","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2008.08.001_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaut.2007.02.016","article-title":"The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts","volume":"28","author":"Ban","year":"2007","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.jaut.2008.08.001_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.autrev.2004.03.003","article-title":"Interferon induced autoimmune thyroid disease (AITD): a model for human autoimmunity","volume":"3","author":"Oppenheim","year":"2004","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841108000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841108000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:00:18Z","timestamp":1760256018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841108000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0896841108000802"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2008.08.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1123970.581075","asserted-by":"object"}]},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2008.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}